Briefing: VIAject NDA filing in Q1 Briefing.com (BIOD) Ticker Alert for In Play 30-Sep-09
14:34 ET Biodel: See major value-drivers in 2010-2011-
Wedbush (5.32) Wedbush says they believe the FDA will
accept the VIAject NDA filing in Q1... Business & Finance > Investments > Stocks (A to Z) > Stocks B > Biodel Inc. (BIOD)
Briefing: VIAject NDA filing in 1Q 2010 Briefing.com (BIOD) Ticker Alert for In Play 30-Sep-09
14:34 ET Biodel: See major value-drivers in 2010-2011-
Wedbush (5.32) Wedbush says they believe the FDA will
accept the VIAject NDA filing in Q1... Business & Finance > Investments > Stocks (A to Z) > Stocks B > Biodel Inc. (BIOD)
Re: What other stocks would SQNM longs recommend? Thursday, August 27, 2009Compugen: The Evolution of
a New Platform for the Rational Design of TherapeuticsIn
March 2008 Compugen announced the development and
validation of its Blockers of Disease... Business & Finance > Investments > Stocks (A to Z) > Stocks S > Sequenom Inc. (SQNM)
STEC in Business Week Briefing.com (STEC) Ticker Alert for In Play 07-Aug-09
08:56 ET STEC Inc profiled in Inside Wall Street section
of Business Week (29.79) Business Week reports STEC,
not exactly a prominent tech stock, may become... Business & Finance > Investments > Stocks (A to Z) > Stocks S > STEC, Inc.
Compugen/Gertsel in Gilder&&39;s new book A whole chapter devoted to Martin Gerstel and Compugen
in George Gilder's new book - The Israel Test.
Chapter 11 - The Shoshana Algorithm.great reviews
too...<a href=\"http://www.amazon.com/gp/product/0980076358\"
rel... Business & Finance > Investments > Stocks (A to Z) > Stocks C > Compugen Ltd. (CGEN)
Re: Hope SEC reviews OWINGS&&39; sale carefully Steve Owens is in a different department - VP of Commercial
Development. The problem was in the R&D organization.
Betty Dragon is the one who's neck is on the line.She
didn't sell any stock so that's... Business & Finance > Investments > Stocks (A to Z) > Stocks S > Sequenom Inc. (SQNM)
Re: next secondary offering will send SQNM below 2 They could also spin off their mass array business
or sell it to a competitor. In the CC Harry said they
would have >$50M in cash at the end of 2009.The
mass array business will be dwarfed by the... Business & Finance > Investments > Stocks (A to Z) > Stocks S > Sequenom Inc. (SQNM)
Briefing analyst summary Briefing.com (SQNM) Ticker Alert for In Play 30-Apr-09
08:07 ET Sequenom: Summary of analyst commentary &
downgrades following yesterday's SEQureDx test
news (14.91) After announcing that... Business & Finance > Investments > Stocks (A to Z) > Stocks S > Sequenom Inc. (SQNM)
Outperform - $16 target Briefing.com (ARYX) Ticker Alert for In Play 30-Apr-09
08:21 ET Aryx Therapeutics initiated with a Outperform
at Hapoalim; tgt $16 (3.82) Hapoalim initiates ARYX
with a Outperform and price target of $16. The... Business & Finance > Investments > Stocks (A to Z) > Stocks A > ARYx Therapeutics, Inc. (ARYX)
Re: American College Of Medical Genetics Started at 10AM - sold out!Noninvasive Prenatal Diagnostics:
Available Tests, the Technology and the Clinical Studies
to Validate New Testing Paradigms... Business & Finance > Investments > Stocks (A to Z) > Stocks S > Sequenom Inc. (SQNM)
Re: low volume,DNA test, Londoneth is right You are full of crap. Anyone can see that londoneth
and alabflor are one and the same. What are the odds
of both of you also posting on CORS? Business & Finance > Investments > Stocks (A to Z) > Stocks S > Sequenom Inc. (SQNM)
Re: New here <a href=\"http://library.corporate-ir.net/library/84/849/84955/items/328081/1B5062E6-C043-4B89-8CB7-510FA5D16A3C_SQNMBarclaysGlobalHealthcare.pdf\"
rel=\"nofollow\">http://libr
ary.corporate-ir.net/library/84/849/84955/items/32
8081... Business & Finance > Investments > Stocks (A to Z) > Stocks S > Sequenom Inc. (SQNM)
Re: DNA OR RNA Briefing.com (SQNM) Ticker Alert for In Play 18-Mar-09
08:27 ET Sequenom: Better clarity on what decides
what Sequenom will launch - Brean Murray (15.02) Brean
Murray wanted to clarify the comment they... Business & Finance > Investments > Stocks (A to Z) > Stocks S > Sequenom Inc. (SQNM)
Barclays: disruptive technology SQNM Sequenom: Continue to believe company has "disruptive
technology in high-value market" - Barclays (16.77
+0.23) Barclays reiterates their Outperform rating
following their Q&A call... Business & Finance > Investments > Stocks (A to Z) > Stocks S > Sequenom Inc. (SQNM)
